- Home
- ELVN vs FBRT Comparison
ELVN vs FBRT Comparison
Compare ELVN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- FBRT
- Stock Information
- Founded
- ELVN 2016
- FBRT 2012
- Country
- ELVN United States
- FBRT United States
- Employees
- ELVN N/A
- FBRT N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- ELVN Health Care
- FBRT Real Estate
- Exchange
- ELVN Nasdaq
- FBRT Nasdaq
- Market Cap
- ELVN 1.1B
- FBRT 1.1B
- IPO Year
- ELVN 2020
- FBRT 1985
- Fundamental
- Price
- ELVN $21.86
- FBRT $12.44
- Analyst Decision
- ELVN Strong Buy
- FBRT Strong Buy
- Analyst Count
- ELVN 5
- FBRT 6
- Target Price
- ELVN $37.80
- FBRT $15.25
- AVG Volume (30 Days)
- ELVN 241.0K
- FBRT 377.1K
- Earning Date
- ELVN 03-13-2025
- FBRT 02-13-2025
- Dividend Yield
- ELVN N/A
- FBRT 11.41%
- EPS Growth
- ELVN N/A
- FBRT N/A
- EPS
- ELVN N/A
- FBRT 0.81
- Revenue
- ELVN N/A
- FBRT $169,684,000.00
- Revenue This Year
- ELVN N/A
- FBRT N/A
- Revenue Next Year
- ELVN N/A
- FBRT $6.56
- P/E Ratio
- ELVN N/A
- FBRT $15.36
- Revenue Growth
- ELVN N/A
- FBRT N/A
- 52 Week Low
- ELVN $10.90
- FBRT $11.96
- 52 Week High
- ELVN $30.03
- FBRT $14.12
- Technical
- Relative Strength Index (RSI)
- ELVN 44.27
- FBRT 45.57
- Support Level
- ELVN $21.45
- FBRT $11.96
- Resistance Level
- ELVN $22.82
- FBRT $12.74
- Average True Range (ATR)
- ELVN 1.55
- FBRT 0.20
- MACD
- ELVN 0.00
- FBRT 0.02
- Stochastic Oscillator
- ELVN 32.63
- FBRT 61.54
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States.